Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data.
Xu Y, Wang J, Li F, Zhang C, Zheng X, Cao Y, Shang D, Hu C, Xu Y, Mi W, Li X, Cao Y, Zhang Y.
Xu Y, et al. Among authors: cao y.
Comput Struct Biotechnol J. 2022 Jan 22;20:838-849. doi: 10.1016/j.csbj.2022.01.022. eCollection 2022.
Comput Struct Biotechnol J. 2022.
PMID: 35222843
Free PMC article.